Laprituximab

• Target:

  EGFR

• Related Pathways:

  Angiogenesis|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors

• Purity:

  0.9962

• Bioactivity:

  Laprituximab (J2898A) is a humanized anti-EGFR antibody used for synthesizing ADC compound Laprituximab emtansine.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1622327-38-1